
Spain ships tens of tonnes of cannabis abroad, yet its patients can only reach two products
Spain authorised 18.3 tonnes of cannabis exports between January and June 2026 — a pace that would finish the year around a fifth above
• Insights
Cannamonitor Insights is our open analysis library. Each piece takes one question about one market — how much was imported, what patients paid, which way a regulator moved — and answers it from the primary record.
• Latest

Spain authorised 18.3 tonnes of cannabis exports between January and June 2026 — a pace that would finish the year around a fifth above
• Method
• Archive
Free to read, no registration. The grid updates itself as new work is published.

Nine months of regulated supply tripled Dutch coffeeshop assortment to 78 products per shop. Flower fell 13%, hash menu prices rose 81%. What the

Portugal exported 66,305 kg of medical cannabis in H1 2026 — 83% of its entire 2025 total, in half the time — while licensed

Australia imported a record 81.1 tonnes of cannabis flower in 2025 and grew another 55.3 tonnes at home — the strongest year on record
• The free layer
Every analysis here starts as work for the monthly brief — where the same markets are tracked every month, with the datapacks and the source trail behind each figure.
€14.2/month, or €142/year.

Retail flower has halved in two years. Canadian import prices are down 28.7% from their peak even as shipment volumes climbed nearly fivefold. And

In May 2026 the United Kingdom listed its first medical hash — Canadian-sourced static hash, crumble and ice-water hash — the clearest sign yet

On 10 July 2026 the Bundestag reshaped Germany’s reimbursed medical cannabis market — striking dried flower from statutory cover and gating extracts, dronabinol and

Switzerland’s 2022 reform made medical cannabis legally accessible to any prescriber, yet two years of federal MeCanna data reveal a market still defined by

Nearly 500 active clinical trials. A 3.5-fold rise in annual trial starts in five years. A decisive pivot away from CBD isolates toward whole-plant,

The UK private medical cannabis market has scaled at a +113% CAGR through 2024. H1 2025 is tracking above 15 tonnes on Q2 run-rate.
• Go deeper
• Start tracking
Insights tell you where a market stood. Essentials keeps you there — every month, every market, with the source trail attached. €14.2/month, or €142/year.